Anti-obesity effects of a-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

Kim, Min-Seon; Park, Joong-Yeol; Namkoong, Cherl; Jang, Pil-Geum; Ryu, Je-Won; Song, Hai-Sun; Yun, Ji-Young; Namgoong, Il-Seong; Ha, Joohun; Park, In-Sun; Lee, In-Kyu; Viollet, Benoit; Youn, Jang Hyun; Lee, Hong-Kyu; Lee, Ki-Up
July 2004
Nature Medicine;Jul2004, Vol. 10 Issue 7, p727
Academic Journal
AMP-activated protein kinase (AMPK) functions as a fuel sensor in the cell and is activated when cellular energy is depleted. Here we report that a-lipoic acid (a-LA), a cofactor of mitochondrial enzymes, decreases hypothalamic AMPK activity and causes profound weight loss in rodents by reducing food intake and enhancing energy expenditure. Activation of hypothalamic AMPK reverses the effects of a-LA on food intake and energy expenditure. Intracerebroventricular (i.c.v.) administration of glucose decreases hypothalamic AMPK activity, whereas inhibition of intracellular glucose utilization through the administration of 2-deoxyglucose increases hypothalamic AMPK activity and food intake. The 2-deoxyglucose-induced hyperphagia is reversed by inhibiting hypothalamic AMPK. Our findings indicate that hypothalamic AMPK is important in the central regulation of food intake and energy expenditure and that a-LA exerts anti-obesity effects by suppressing hypothalamic AMPK activity.NOTE: In the version of this article initially published online, the name of an author was misspelled. The name of the twelfth author should be “Benoit Viollet”. This error has been corrected for the HTML and print versions of the article


Related Articles

  • Did a muscle fuel gauge conquer the brain? Pocai, Alessandro; Muse, Evan David; Rossetti, Luciano // Nature Medicine;Jan2006, Vol. 12 Issue 1, p50 

    The article reports the findings of the recent study suggesting that biochemical fuel sensor participates in the hypothalamic recognition of the body's energy status. The regulation of adenylic acid-activated protein kinase (AMPK) provides a crucial point of convergence for hormonal and...

  • Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Howard, Jane K; Cave, Belinda J; Oksanen, Laura J; Tzameli, Iphigenia; Bjørbæk, Christian; Flier, Jeffrey S // Nature Medicine;Jul2004, Vol. 10 Issue 7, p734 

    Leptin is an adipocyte-derived hormone that regulates energy balance and neuroendocrine function primarily by acting on specific hypothalamic pathways. Resistance to the weight reducing effects of leptin is a feature of most cases of human and rodent obesity, yet the molecular basis of leptin...

  • Track 2: Cellular mechanisms and pathophysiology.  // International Journal of Obesity & Related Metabolic Disorders;May2004 Supplement, Vol. 28, pS7 

    Presents an abstract of the article "AMP-Activated Protein Kinase: A Sensor of Cellular Energy and Key Player in Diabetes, Obesity and the Metabolic Syndrome," by D. Grahame Hardie.

  • Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Mori, Hiroyuki; Hanada, Reiko; Hanada, Toshikatsu; Aki, Daisuke; Mashima, Ryuichi; Nishinakamura, Hitomi; Torisu, Takehiro; Chien, Kenneth R; Yasukawa, Hideo; Yoshimura, Akihiko // Nature Medicine;Jul2004, Vol. 10 Issue 7, p739 

    Leptin is an adipocyte-derived hormone that plays a key role in energy homeostasis, yet resistance to leptin is a feature of most cases of obesity in humans and rodents. In vitro analysis suggested that the suppressor of cytokine signaling-3 (Socs3) is a negative-feedback regulator of leptin...

  • Activation of Vascular Protein Kinase C-β Inhibits Akt-Dependent Endothelial Nitric Oxide Synthase Function in Obesity-Associated Insulin Resistance. Naruse, Keiko; Rask-Madsen, Christian; Takahara, Noriko; Ha, Sung-woo; Suzuma, Kiyoshi; Way, Kerrie J.; Jacobs, Judith R. C.; Clermont, Allen C.; Ueki, Kohjiro; Ohshiro, Yuzuru; Zhang, Junqing; Goldfine, Allison B.; King, George L. // Diabetes;Mar2006, Vol. 55 Issue 3, p691 

    Activation of protein kinase C (PKC) in vascular tissue is associated with endothelial dysfunction and insulin resistance. However, the effect of vascular PKC activation on insulin-stimulated endothelial nitric oxide (NO) synthase (eNOS) regulation has not been characterized in...

  • AMPK: a nutrient and energy sensor that maintains energy homeostasis. Hardie, D. Grahame; Ross, Fiona A.; Hawley, Simon A. // Nature Reviews Molecular Cell Biology;Apr2012, Vol. 13 Issue 4, p251 

    AMP-activated protein kinase (AMPK) is a crucial cellular energy sensor. Once activated by falling energy status, it promotes ATP production by increasing the activity or expression of proteins involved in catabolism while conserving ATP by switching off biosynthetic pathways. AMPK also...

  • p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-Uncoupling in Obesity. Yi Yu; Rajapakse, Angana; Montani, Jean-Pierre; Zhihong Yang; Xiu-Fen Ming // Cardiovascular Diabetology;2014, Vol. 13 Issue 1, p1 

    Background Endothelial nitric oxide synthase (eNOS)-uncoupling links obesity-associated insulin resistance and type-II diabetes to the increased incidence of cardiovascular disease. Studies have indicated that increased arginase is involved in eNOS-uncoupling through competing with the substrate...

  • Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487. Heathcote, Helen R.; Mancini, Sarah J.; Strembitska, Anastasiya; Jamal, Kunzah; Reihill, James A.; Palmer, Timothy M.; Gould, Gwyn W.; Salt, Ian P. // Biochemical Journal;12/15/2016, Vol. 473 Issue 24, p4681 

    The key metabolic regulator, AMP-activated protein kinase (AMPK), is reported to be down-regulated in metabolic disorders, but the mechanisms are poorly characterised. Recent studies have identified phosphorylation of the AMPKα1/α2 catalytic subunit isoforms at Ser487/491, respectively, as...

  • Overview of human obesity and central mechanisms regulating energy homeostasis. Crowley, Vivion E. F. // Annals of Clinical Biochemistry;May2008, Vol. 45 Issue 3, p245 

    Obesity is now regarded as a global epidemic affecting both adults and children, and is associated with significant morbidity and mortality. Thus the effective management of obesity has become an important clinical focus. Therefore, an understanding of the pathways controlling appetite, satiety...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics